Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
mi
from
Lombard, IL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
mi
from
Lombard, IL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Springfield, IL
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Shreveport, LA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Brighton, MA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Brighton, MA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lansing, MI
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Paul, MN
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Paterson, NJ
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Paterson, NJ
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ridgewood, NJ
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
East Syracuse, NY
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Syracuse, NY
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Elyria, OH
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Elyria, OH
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Study for Atrial Fibrillation Reduction (SAFARI)
Study for Atrial Fibrillation Reduction (SAFARI)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
P. Stradins University Hospital
mi
from
Riga,
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
P. Stradins University Hospital
mi
from
Riga,
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital - Columbia University Medical Center
mi
from
New York, NY
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital - Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
The Lindner Center for Research and Education at The Christ Hospital
mi
from
Cincinnati, OH
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
The Lindner Center for Research and Education at The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
York Hospital
mi
from
York, PA
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
HealthEast St. Joseph's Hospital
mi
from
Saint Paul, MN
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
HealthEast St. Joseph's Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated:  12/31/1969
The Heart Hospital Baylor Plano
mi
from
Plano, TX
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Status: Enrolling
Updated: 12/31/1969
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary Arteries
Status: Enrolling
Updated:  12/31/1969
East Carolina Heart Institute at Vidant Medical Center
mi
from
Greenville, NC
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary Arteries
Status: Enrolling
Updated: 12/31/1969
East Carolina Heart Institute at Vidant Medical Center
mi
from
Greenville, NC
Click here to add this to my saved trials
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
Status: Enrolling
Updated:  12/31/1969
WakeMed
mi
from
Raleigh, NC
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
MyoStrain CMR Testing of Ischemia With Low Levels of Stress
Status: Enrolling
Updated: 12/31/1969
WakeMed
mi
from
Raleigh, NC
Click here to add this to my saved trials
Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)
Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)
Targeting Pulsatile Load to Increase Exercise Capacity and Quality of Life After Aortic Valve Replacement for Severe Aortic Stenosis (PULSE AS)
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
High-Shear Microfluidic Thrombosis Assay
Characterization of a Novel High-Shear Thrombosis Assay in Normal and Aspirin-treated Patients
Status: Enrolling
Updated:  12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
High-Shear Microfluidic Thrombosis Assay
Characterization of a Novel High-Shear Thrombosis Assay in Normal and Aspirin-treated Patients
Status: Enrolling
Updated: 12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
MUSC Gazes Research Institue
mi
from
Charleston, SC
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
MUSC Gazes Research Institue
mi
from
Charleston, SC
Click here to add this to my saved trials
Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Monocyte Phenotypic Changes in Heart Failure
Monocyte Phenotypic Changes in Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Monocyte Phenotypic Changes in Heart Failure
Monocyte Phenotypic Changes in Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
CATS-CARE: Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
CATS-CARE: Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF)
Characterizing Acute Heart Failure With Reduced Ejection Fraction Hospitalization Outcomes
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Princeton, NJ
A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF)
Characterizing Acute Heart Failure With Reduced Ejection Fraction Hospitalization Outcomes
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Princeton, NJ
Click here to add this to my saved trials
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Dr. Robert Snyder
mi
from
Tamarac, FL
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Dr. Robert Snyder
mi
from
Tamarac, FL
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
National Center for Limb Preservation
mi
from
Niles, IL
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
National Center for Limb Preservation
mi
from
Niles, IL
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center, Division of Podiatry
mi
from
Boston, MA
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center, Division of Podiatry
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Center for Curative and Palliative Wound Care, Calvary Hospital
mi
from
Bronx, NY
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Center for Curative and Palliative Wound Care, Calvary Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
State Univ of New York at Stony Brook
mi
from
Stony Brook, NY
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
State Univ of New York at Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill, Division of Vascular Surgery
mi
from
Durham, NC
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill, Division of Vascular Surgery
mi
from
Durham, NC
Click here to add this to my saved trials